Neuromuscular Blocking Drugs Market Share

On the basis of regional analysis, the neuromuscular blocking drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market for North America industry is likely to account for largest revenue share by 2036, backed by high geriatric population, increasing research and development initiatives by the government, increasing safety and efficacy of the drug and more number of people opting for surgical treatments. On the other hand, the neuromuscular blocking drugs market in Asia Pacific is anticipated to record the highest CAGR on the back of growing geriatric population, increasing investments in the healthcare sector and increasing research and development initiatives in the region.